Filing Details
- Accession Number:
- 0001193805-21-001163
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-11 09:05:43
- Reporting Period:
- 2021-08-10
- Accepted Time:
- 2021-08-11 09:05:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1280776 | Immunic Inc. | IMUX | Pharmaceutical Preparations (2834) | 562358443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1724623 | Glenn Whaley | 1200 Avenue Of The Americas, Suite 200 New York NY 10036 | Pfo And Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-10 | 1,500 | $9.85 | 3,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average price of 1,500 shares of common stock of Immunic, Inc. purchased by the Reporting Person in multiple transactions on August 10, 2021 at prices ranging from $9.65 to $9.95 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
